<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37555859</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>146</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>TDP-43 differentially propagates to induce antero- and retrograde degeneration in the corticospinal circuits in mouse focal ALS models.</ArticleTitle><Pagination><StartPage>611</StartPage><EndPage>629</EndPage><MedlinePgn>611-629</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-023-02615-8</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by TDP-43 inclusions in the cortical and spinal motor neurons. It remains unknown whether and how pathogenic TDP-43 spreads across neural connections to progress degenerative processes in the cortico-spinal motor circuitry. Here we established novel mouse ALS models that initially induced mutant TDP-43 inclusions in specific neuronal or cell types in the motor circuits, and investigated whether TDP-43 and relevant pathological processes spread across neuronal or cellular connections. We first developed ALS models that primarily induced TDP-43 inclusions in the corticospinal neurons, spinal motor neurons, or forelimb skeletal muscle, by using adeno-associated virus (AAV) expressing mutant TDP-43. We found that TDP-43 induced in the corticospinal neurons was transported along the axons anterogradely and transferred to the oligodendrocytes along the corticospinal tract (CST), coinciding with mild axon degeneration. In contrast, TDP-43 introduced in the spinal motor neurons did not spread retrogradely to the cortical or spinal neurons; however, it induced an extreme loss of spinal motor neurons and subsequent degeneration of neighboring spinal neurons, suggesting a degenerative propagation in a retrograde manner in the spinal cord. The intraspinal degeneration further led to severe muscle atrophy. Finally, TDP-43 induced in the skeletal muscle did not propagate pathological events to spinal neurons retrogradely. Our data revealed that mutant TDP-43 spread across neuro-glial connections anterogradely in the corticospinal pathway, whereas it exhibited different retrograde degenerative properties in the spinal circuits. This suggests that pathogenic TDP-43 may induce distinct antero- and retrograde mechanisms of degeneration in the motor system in ALS.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsuboguchi</LastName><ForeName>Shintaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Niigata, 951-8585, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Yuka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of System Pathology for Neurological Disorders, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishihara</LastName><ForeName>Tomohiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Niigata, 951-8585, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Taisuke</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Tokiharu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of System Pathology for Neurological Disorders, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koyama</LastName><ForeName>Akihide</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Legal Medicine, Graduate School of Medicine and Dental Sciences, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mori</LastName><ForeName>Hideki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Niigata, 951-8585, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koike</LastName><ForeName>Yuka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Niigata, 951-8585, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onodera</LastName><ForeName>Osamu</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Niigata, 951-8585, Japan. onodera@bri.niigata-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata, Japan. onodera@bri.niigata-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueno</LastName><ForeName>Masaki</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1484-9921</Identifier><AffiliationInfo><Affiliation>Department of System Pathology for Neurological Disorders, Brain Research Institute, Niigata University, Niigata, Japan. ms-ueno@bri.niigata-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012183" MajorTopicYN="Y">Retrograde Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Corticospinal tract</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Spreading</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>12</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>11</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37555859</ArticleId><ArticleId IdType="doi">10.1007/s00401-023-02615-8</ArticleId><ArticleId IdType="pii">10.1007/s00401-023-02615-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alami NH, Smith RB, Carrasco MA, Williams LA, Winborn CS, Han SS et al (2014) Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 81:536&#x2013;543</Citation><ArticleIdList><ArticleId IdType="pubmed">24507191</ArticleId><ArticleId IdType="pmc">3939050</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2013.12.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Alaynick WA, Jessell TM, Pfaff SL (2011) SnapShot: spinal cord development. Cell 146:178</Citation><ArticleIdList><ArticleId IdType="pubmed">21729788</ArticleId><ArticleId IdType="pmc">3158655</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2011.06.038</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602&#x2013;611</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlotta P, Molyneaux BJ, Chen J, Inoue J, Kominami R, Macklis JD (2005) Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 45:207&#x2013;221</Citation><ArticleIdList><ArticleId IdType="pubmed">15664173</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2004.12.036</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold ES, Ling S-C, Huelga SC, Lagier-Tourenne C, Polymenidou M, Ditsworth D et al (2013) ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci USA 110:E736&#x2013;E745</Citation><ArticleIdList><ArticleId IdType="pubmed">23382207</ArticleId><ArticleId IdType="pmc">3581922</ArticleId><ArticleId IdType="doi">10.1073/pnas.1222809110</ArticleId></ArticleIdList></Reference><Reference><Citation>Asakawa K, Handa H, Kawakami K (2020) Optogenetic modulation of TDP-43 oligomerization accelerates ALS-related pathologies in the spinal motor neurons. Nature Commun 11:1004</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-14815-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Auguste YS, Ferro A, Kahng JA, Xavier AM, Dixon JR, Vrudhula U et al (2022) Oligodendrocyte precursor cells engulf synapses during circuit remodeling in mice. Nat Neurosci 25:1273&#x2013;1278</Citation><ArticleIdList><ArticleId IdType="pubmed">36171430</ArticleId><ArticleId IdType="pmc">9534756</ArticleId><ArticleId IdType="doi">10.1038/s41593-022-01170-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Brettschneider J, Ludolph AC, Lee VM, Trojanowski JQ, Del Tredici K (2013) Amyotrophic lateral sclerosis&#x2014;a model of corticofugal axonal spread. Nat Rev Neurol 9:708&#x2013;714</Citation><ArticleIdList><ArticleId IdType="pubmed">24217521</ArticleId><ArticleId IdType="pmc">3943211</ArticleId><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Ludolph A, Thal DR, Del Tredici K (2010) Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord. Acta Neuropathol 120:67&#x2013;74</Citation><ArticleIdList><ArticleId IdType="pubmed">20379728</ArticleId><ArticleId IdType="doi">10.1007/s00401-010-0683-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Ludolph AC, Neumann M, Ravits J, Del Tredici K (2017) Pathological TDP-43 changes in Betz cells differ from those in bulbar and spinal &#x3b1;-motoneurons in sporadic amyotrophic lateral sclerosis. Acta Neuropathol 133:79&#x2013;90</Citation><ArticleIdList><ArticleId IdType="pubmed">27757524</ArticleId><ArticleId IdType="doi">10.1007/s00401-016-1633-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M et al (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74:20&#x2013;38</Citation><ArticleIdList><ArticleId IdType="pubmed">23686809</ArticleId><ArticleId IdType="pmc">3785076</ArticleId><ArticleId IdType="doi">10.1002/ana.23937</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchanan J, Elabbady L, Collman F, Jorstad NL, Bakken TE, Ott C et al (2022) Oligodendrocyte precursor cells ingest axons in the mouse neocortex. Proc Natl Acad Sci USA 119:e2202580119</Citation><ArticleIdList><ArticleId IdType="pubmed">36417438</ArticleId><ArticleId IdType="pmc">9889886</ArticleId><ArticleId IdType="doi">10.1073/pnas.2202580119</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM-Y, Hatanpaa KJ et al (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5&#x2013;22</Citation><ArticleIdList><ArticleId IdType="pubmed">17579875</ArticleId><ArticleId IdType="pmc">2827877</ArticleId><ArticleId IdType="doi">10.1007/s00401-007-0237-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW, Josephs KA, Amador-Ortiz C (2007) TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol 114:71&#x2013;79</Citation><ArticleIdList><ArticleId IdType="pubmed">17569066</ArticleId><ArticleId IdType="doi">10.1007/s00401-007-0234-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X, Xiang Z, Qin C, Chen Y, Tian H, Meng L et al (2021) Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice. Acta Neuropathol Commun 9:15</Citation><ArticleIdList><ArticleId IdType="pubmed">33461623</ArticleId><ArticleId IdType="pmc">7814549</ArticleId><ArticleId IdType="doi">10.1186/s40478-020-01112-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Dols-Icardo O, Montal V, Sirisi S, L&#xf3;pez-Pernas G, Cervera-Carles L, Querol-Vilaseca M et al (2020) Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm 7:e829</Citation><ArticleIdList><ArticleId IdType="pubmed">32669313</ArticleId><ArticleId IdType="pmc">7371375</ArticleId><ArticleId IdType="doi">10.1212/NXI.0000000000000829</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Weber M (2001) The motor cortex and amyotrophic lateral sclerosis. Muscle Nerve 24:564&#x2013;573</Citation><ArticleIdList><ArticleId IdType="pubmed">11268031</ArticleId><ArticleId IdType="doi">10.1002/mus.1042</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C, Bassell GJ, Rossoll W (2012) The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Human Mol Gen 21:3703&#x2013;3718</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds205</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima M, Tan R, Halliday GM, Kril JJ (2015) Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways. Acta Neuropathol Commun 3:47</Citation><ArticleIdList><ArticleId IdType="pubmed">26216351</ArticleId><ArticleId IdType="pmc">4517552</ArticleId><ArticleId IdType="doi">10.1186/s40478-015-0226-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler MS, Strobel B, Freischmidt A, Helferich AM, Kappel J, Brewer BM et al (2015) TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol 211:897&#x2013;911</Citation><ArticleIdList><ArticleId IdType="pubmed">26598621</ArticleId><ArticleId IdType="pmc">4657165</ArticleId><ArticleId IdType="doi">10.1083/jcb.201504057</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F, Stein B, Partain M, Elman LB, McCluskey LF, Xie SX et al (2011) Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy. Acta Neuropathol 121:509&#x2013;517</Citation><ArticleIdList><ArticleId IdType="pubmed">21225272</ArticleId><ArticleId IdType="pmc">3125638</ArticleId><ArticleId IdType="doi">10.1007/s00401-011-0797-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D et al (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63:535&#x2013;538</Citation><ArticleIdList><ArticleId IdType="pubmed">18288693</ArticleId><ArticleId IdType="pmc">2747362</ArticleId><ArticleId IdType="doi">10.1002/ana.21344</ArticleId></ArticleIdList></Reference><Reference><Citation>Gousset K, Schiff E, Langevin C, Marijanovic Z, Caputo A, Browman DT et al (2009) Prions hijack tunnelling nanotubes for intercellular spread. Nat Cell Biol 11:328&#x2013;336</Citation><ArticleIdList><ArticleId IdType="pubmed">19198598</ArticleId><ArticleId IdType="doi">10.1038/ncb1841</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromicho M, Figueiral M, Uysal H, Grosskreutz J, Kuzma-Kozakiewicz M et al (2020) Spreading in ALS: the relative impact of upper and lower motor neuron involvement. Ann Clin Transl Neurol 7:1181&#x2013;1192</Citation><ArticleIdList><ArticleId IdType="pubmed">32558369</ArticleId><ArticleId IdType="pmc">7359118</ArticleId><ArticleId IdType="doi">10.1002/acn3.51098</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Kalambogias J, Yoshioka S, Han W, Li Z, Kawasawa YI et al (2017) Control of species-dependent cortico-motoneuronal connections underlying manual dexterity. Science 357:400&#x2013;404</Citation><ArticleIdList><ArticleId IdType="pubmed">28751609</ArticleId><ArticleId IdType="pmc">5774341</ArticleId><ArticleId IdType="doi">10.1126/science.aan3721</ArticleId></ArticleIdList></Reference><Reference><Citation>Hock EM, Polymenidou M (2016) Prion-like propagation as a pathogenic principle in frontotemporal dementia. J Neurochem 138:163&#x2013;183</Citation><ArticleIdList><ArticleId IdType="pubmed">27502124</ArticleId><ArticleId IdType="pmc">6680357</ArticleId><ArticleId IdType="doi">10.1111/jnc.13668</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz LM, Kwong LK, Lee EB, Chen-Plotkin A, Swanson E, Unger T et al (2011) Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Investig 121:726&#x2013;738</Citation><ArticleIdList><ArticleId IdType="pubmed">21206091</ArticleId><ArticleId IdType="pmc">3026736</ArticleId><ArticleId IdType="doi">10.1172/JCI44867</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, Eid L, Parent M, Soucy G, Bareil C, Riku Y et al (2016) Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain 139:3187&#x2013;3201</Citation><ArticleIdList><ArticleId IdType="pubmed">27679482</ArticleId><ArticleId IdType="pmc">5840881</ArticleId><ArticleId IdType="doi">10.1093/brain/aww237</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii T, Kawakami E, Endo K, Misawa H, Watabe K (2017) Formation and spreading of TDP-43 aggregates in cultured neuronal and glial cells demonstrated by time-lapse imaging. PLoS ONE 12:e0179375</Citation><ArticleIdList><ArticleId IdType="pubmed">28599005</ArticleId><ArticleId IdType="pmc">5466347</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0179375</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, Ostrow LW et al (2013) Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci 16:571&#x2013;579</Citation><ArticleIdList><ArticleId IdType="pubmed">23542689</ArticleId><ArticleId IdType="pmc">3637847</ArticleId><ArticleId IdType="doi">10.1038/nn.3357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke YD, van Hummel A, Stevens CH, Gladbach A, Ippati S, Bi M et al (2015) Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS. Acta Neuropathol 130:661&#x2013;678</Citation><ArticleIdList><ArticleId IdType="pubmed">26437864</ArticleId><ArticleId IdType="doi">10.1007/s00401-015-1486-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O et al (2011) Amyotrophic lateral sclerosis. Lancet 377:942&#x2013;955</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama A, Sugai A, Kato T, Ishihara T, Shiga A, Toyoshima Y et al (2016) Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43. Nucleic Acids Res 44:5820&#x2013;5836</Citation><ArticleIdList><ArticleId IdType="pubmed">27257061</ArticleId><ArticleId IdType="pmc">4937342</ArticleId><ArticleId IdType="doi">10.1093/nar/gkw499</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, Lee VM-Y, Trojanowski JQ (2012) Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci 13:38&#x2013;50</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3121</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemon R (2019) Recent advances in our understanding of the primate corticospinal system. F1000Res 8:274</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.17445.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481&#x2013;487</Citation><ArticleIdList><ArticleId IdType="pubmed">28099414</ArticleId><ArticleId IdType="pmc">5404890</ArticleId><ArticleId IdType="doi">10.1038/nature21029</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F, Tada M, Kon T, Miki Y, Tanji K, Kurotaki H et al (2019) Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta Neuropathol Commun 7:165</Citation><ArticleIdList><ArticleId IdType="pubmed">31661037</ArticleId><ArticleId IdType="pmc">6816170</ArticleId><ArticleId IdType="doi">10.1186/s40478-019-0824-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F, Tanji K, Zhang H-X, Nishihira Y, Tan C-F, Takahashi H et al (2008) Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol 116:193&#x2013;203</Citation><ArticleIdList><ArticleId IdType="pubmed">18560845</ArticleId><ArticleId IdType="doi">10.1007/s00401-008-0396-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison BM, Hof PR, Morrison JH (1998) Determinants of neuronal vulnerability in neurodegenerative diseases. Ann Neurol 44:S32&#x2013;S44</Citation><ArticleIdList><ArticleId IdType="pubmed">9749571</ArticleId><ArticleId IdType="doi">10.1002/ana.410440706</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura Y, Ueno M, Niehaus JK, Lang RA, Zheng Y, Yoshida Y (2021) Modulation of both intrinsic and extrinsic factors additively promotes rewiring of corticospinal circuits after spinal cord injury. J Neurosci 41:10247&#x2013;10260</Citation><ArticleIdList><ArticleId IdType="pubmed">34759029</ArticleId><ArticleId IdType="pmc">8672694</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.2649-20.2021</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y et al (2009) Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol 117:137&#x2013;149</Citation><ArticleIdList><ArticleId IdType="pubmed">19125255</ArticleId><ArticleId IdType="pmc">2693625</ArticleId><ArticleId IdType="doi">10.1007/s00401-008-0477-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Sampathu DM, Trojanowski JQ, Lee VM-Y (2007) TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch Neurol 64:1388&#x2013;1394</Citation><ArticleIdList><ArticleId IdType="pubmed">17923623</ArticleId><ArticleId IdType="doi">10.1001/archneur.64.10.1388</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId><ArticleId IdType="doi">10.1126/science.1134108</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira Y, Tan C-F, Onodera O, Toyoshima Y, Yamada M, Morita T et al (2008) Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol 116:169&#x2013;182</Citation><ArticleIdList><ArticleId IdType="pubmed">18481073</ArticleId><ArticleId IdType="doi">10.1007/s00401-008-0385-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M, Scott C, Gamarallage MP, Lunn D, Carpenter K, McDonough E et al (2020) Quantitative patterns of motor cortex proteinopathy across ALS genotypes. Acta Neuropathol Commun 8:98</Citation><ArticleIdList><ArticleId IdType="pubmed">32616036</ArticleId><ArticleId IdType="pmc">7331195</ArticleId><ArticleId IdType="doi">10.1186/s40478-020-00961-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T et al (2013) Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep 4:124&#x2013;134</Citation><ArticleIdList><ArticleId IdType="pubmed">23831027</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2013.06.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto K, Hirai S, Shoji M, Senoh Y, Yamazaki T (1990) Axonal swellings in the corticospinal tracts in amyotrophic lateral sclerosis. Acta Neuropathol 80:222&#x2013;226</Citation><ArticleIdList><ArticleId IdType="pubmed">2202191</ArticleId><ArticleId IdType="doi">10.1007/BF00308929</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyanagi K, Ikuta F, Horikawa Y (1989) Evidence for sequential degeneration of the neurons in the intermediate zone of the spinal cord in amyotrophic lateral sclerosis: a topographic and quantitative investigation. Acta Neuropathol 77:343&#x2013;349</Citation><ArticleIdList><ArticleId IdType="pubmed">2711828</ArticleId><ArticleId IdType="doi">10.1007/BF00687368</ArticleId></ArticleIdList></Reference><Reference><Citation>Paxions G, Franklin K (2001) The mouse brain in stereotaxic coordinates. Academic Express, San Diego</Citation></Reference><Reference><Citation>Payne SC, Bartlett CA, Savigni DL, Harvey AR, Dunlop SA, Fitzgerald M (2013) Early proliferation does not prevent the loss of oligodendrocyte progenitor cells during the chronic phase of secondary degeneration in a CNS white matter tract. PLoS ONE 8:e65710</Citation><ArticleIdList><ArticleId IdType="pubmed">23776532</ArticleId><ArticleId IdType="pmc">3679191</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0065710</ArticleId></ArticleIdList></Reference><Reference><Citation>Peled S, Sade D, Bram Y, Porat Z, Kreiser T, Mimouni M et al (2017) Single cell imaging and quantification of TDP-43 and &#x3b1;-synuclein intercellular propagation. Sci Rep 7:1&#x2013;12</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00657-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Cleveland DW (2011) The seeds of neurodegeneration: prion-like spreading in ALS. Cell 147:498&#x2013;508</Citation><ArticleIdList><ArticleId IdType="pubmed">22036560</ArticleId><ArticleId IdType="pmc">3220614</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2011.10.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta S, Xu Y, Restrepo CR, Kwong LK, Zhang B, Brown HJ et al (2018) Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun 9:4220</Citation><ArticleIdList><ArticleId IdType="pubmed">30310141</ArticleId><ArticleId IdType="pmc">6181940</ArticleId><ArticleId IdType="doi">10.1038/s41467-018-06548-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J, Laurie P, Fan Y, Moore DH (2007) Implications of ALS focality: rostral&#x2013;caudal distribution of lower motor neuron loss postmortem. Neurology 68:1576&#x2013;1582</Citation><ArticleIdList><ArticleId IdType="pubmed">17485644</ArticleId><ArticleId IdType="doi">10.1212/01.wnl.0000261045.57095.56</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J, Paul P, Jorg C (2007) Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 68:1571&#x2013;1575</Citation><ArticleIdList><ArticleId IdType="pubmed">17485643</ArticleId><ArticleId IdType="doi">10.1212/01.wnl.0000260965.20021.47</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits JM, La Spada AR (2009) ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 73:805&#x2013;811</Citation><ArticleIdList><ArticleId IdType="pubmed">19738176</ArticleId><ArticleId IdType="pmc">2739608</ArticleId><ArticleId IdType="doi">10.1212/WNL.0b013e3181b6bbbd</ArticleId></ArticleIdList></Reference><Reference><Citation>Riku Y (2020) Reappraisal of the anatomical spreading and propagation hypothesis about TDP-43 aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Neuropathology 40:426&#x2013;435</Citation><ArticleIdList><ArticleId IdType="pubmed">32157757</ArticleId><ArticleId IdType="doi">10.1111/neup.12644</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, Chen H-J, Shaw CE (2015) TDP-43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets. Neurotherapeutics 12:352&#x2013;363</Citation><ArticleIdList><ArticleId IdType="pubmed">25652699</ArticleId><ArticleId IdType="pmc">4404432</ArticleId><ArticleId IdType="doi">10.1007/s13311-015-0338-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Shodai A, Morimura T, Ido A, Uchida T, Ayaki T, Takahashi R et al (2013) Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43). J Biol Chem 288:14886&#x2013;14905</Citation><ArticleIdList><ArticleId IdType="pubmed">23558684</ArticleId><ArticleId IdType="pmc">3663511</ArticleId><ArticleId IdType="doi">10.1074/jbc.M113.451849</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P, Newcombe J, Troakes C, Simone R, Chen Y-R et al (2016) In vitro prion-like behaviour of TDP-43 in ALS. Neurobiol Dis 96:236&#x2013;247</Citation><ArticleIdList><ArticleId IdType="pubmed">27590623</ArticleId><ArticleId IdType="pmc">5113659</ArticleId><ArticleId IdType="doi">10.1016/j.nbd.2016.08.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668&#x2013;1672</Citation><ArticleIdList><ArticleId IdType="pubmed">18309045</ArticleId><ArticleId IdType="pmc">7116650</ArticleId><ArticleId IdType="doi">10.1126/science.1154584</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens B, Guiloff RJ, Navarrete R, Newman P, Nikhar N, Lewis P (2006) Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease. A morphometric study. J Neurol Sci 244:41&#x2013;58</Citation><ArticleIdList><ArticleId IdType="pubmed">16487542</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2005.12.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugai A, Kato T, Koyama A, Koike Y, Konno T, Ishihara T et al (2019) Non-genetically modified models exhibit TARDBP mRNA increase due to perturbed TDP-43 autoregulation. Neurobiol Dis 130:104534</Citation><ArticleIdList><ArticleId IdType="pubmed">31310801</ArticleId><ArticleId IdType="doi">10.1016/j.nbd.2019.104534</ArticleId></ArticleIdList></Reference><Reference><Citation>Svahn AJ, Don EK, Badrock AP, Cole NJ, Graeber MB, Yerbury JJ et al (2018) Nucleo-cytoplasmic transport of TDP-43 studied in real time: impaired microglia function leads to axonal spreading of TDP-43 in degenerating motor neurons. Acta Neuropathol 136:445&#x2013;459</Citation><ArticleIdList><ArticleId IdType="pubmed">29943193</ArticleId><ArticleId IdType="pmc">6096729</ArticleId><ArticleId IdType="doi">10.1007/s00401-018-1875-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanji K, Zhang HX, Mori F, Kakita A, Takahashi H, Wakabayashi K (2012) p62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions. J Neurosci Res 90:2034&#x2013;2042</Citation><ArticleIdList><ArticleId IdType="pubmed">22674379</ArticleId><ArticleId IdType="doi">10.1002/jnr.23081</ArticleId></ArticleIdList></Reference><Reference><Citation>Tawara N, Yamashita S, Kawakami K, Kurashige T, Zhang Z et al (2018) Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions. Exp Neurol 309:169&#x2013;180</Citation><ArticleIdList><ArticleId IdType="pubmed">30130494</ArticleId><ArticleId IdType="doi">10.1016/j.expneurol.2018.08.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida A, Sasaguri H, Kimura N, Tajiri M, Ohkubo T, Ono F et al (2012) Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43. Brain 135:833&#x2013;846</Citation><ArticleIdList><ArticleId IdType="pubmed">22252998</ArticleId><ArticleId IdType="pmc">3286326</ArticleId><ArticleId IdType="doi">10.1093/brain/awr348</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno M, Nakamura Y, Li J, Gu Z, Niehaus J, Maezawa M et al (2018) Corticospinal circuits from the sensory and motor cortices differentially regulate skilled movements through distinct spinal interneurons. Cell Rep 23:1286&#x2013;1300</Citation><ArticleIdList><ArticleId IdType="pubmed">29719245</ArticleId><ArticleId IdType="pmc">6608728</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2018.03.137</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, Spiller KJ, Ge G, Zheng A, Xu Y, Zhou M et al (2015) Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol 130:643&#x2013;660</Citation><ArticleIdList><ArticleId IdType="pubmed">26197969</ArticleId><ArticleId IdType="pmc">5127391</ArticleId><ArticleId IdType="doi">10.1007/s00401-015-1460-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh DM, Selkoe DJ (2016) A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. Nat Rev Neurosci 17:251&#x2013;260</Citation><ArticleIdList><ArticleId IdType="pubmed">26988744</ArticleId><ArticleId IdType="pmc">6701169</ArticleId><ArticleId IdType="doi">10.1038/nrn.2016.13</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts RJ, Schuldiner O, Perrino J, Larsen C, Luo L (2004) Glia engulf degenerating axons during developmental axon pruning. Curr Biol 14:678&#x2013;684</Citation><ArticleIdList><ArticleId IdType="pubmed">15084282</ArticleId><ArticleId IdType="doi">10.1016/j.cub.2004.03.035</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Boillee S, Roberts EA, Garcia ML, McAlonis-Downes M, Mikse OR et al (2008) Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci USA 105:7594&#x2013;7599</Citation><ArticleIdList><ArticleId IdType="pubmed">18492803</ArticleId><ArticleId IdType="pmc">2396671</ArticleId><ArticleId IdType="doi">10.1073/pnas.0802556105</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Cheng X, Shen J, Xie B, Zhao X, Zhang Z et al (2016) A novel approach for amplification and purification of mouse oligodendrocyte progenitor cells. Front Cell Neurosci 10:203</Citation><ArticleIdList><ArticleId IdType="pubmed">27597818</ArticleId><ArticleId IdType="pmc">4992724</ArticleId><ArticleId IdType="doi">10.3389/fncel.2016.00203</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoseki A, Shiga A, Tan CF, Tagawa A, Kaneko H, Koyama A et al (2008) TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol 63:538&#x2013;542</Citation><ArticleIdList><ArticleId IdType="pubmed">18438952</ArticleId><ArticleId IdType="doi">10.1002/ana.21392</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeineddine R, Whiten DR, Farrawell NE, McAlary L, Hanspal MA, Kumita JR et al (2017) Flow cytometric measurement of the cellular propagation of TDP-43 aggregation. Prion 11:195&#x2013;204</Citation><ArticleIdList><ArticleId IdType="pubmed">28486039</ArticleId><ArticleId IdType="pmc">5480386</ArticleId><ArticleId IdType="doi">10.1080/19336896.2017.1314426</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Chen Y, Wang X, Tian H, Liu H, Xiang Z et al (2021) Spreading of pathological TDP-43 along corticospinal tract axons induces ALS-like phenotypes in Atg5(+/-) mice. Int J Biol Sci 17:390&#x2013;401</Citation><ArticleIdList><ArticleId IdType="pubmed">33613100</ArticleId><ArticleId IdType="pmc">7893595</ArticleId><ArticleId IdType="doi">10.7150/ijbs.53872</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>